Cytostatics as hazardous chemicals in healthcare workers' environment.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AffiliationNofer Institute of Occupational Medicine
MetadataShow full item record
AbstractCytostatics not only induce significant side-effects in patients treated oncologically but also pose a threat to the health of occupationally exposed healthcare workers: pharmacists, physicians, nurses and other personnel. Since the 1970s numerous reports from various countries have documented the contamination of working areas with cytostatics and the presence of drugs/metabolites in the urine or blood of healthcare employees, which directly indicates the occurrence of occupational exposure to these drugs. In Poland the significant scale of occupational exposure to cytostatics is also confirmed by the data collected in the central register of occupational carcinogens/mutagens kept by the Nofer Institute of Occupational Medicine. The assessment of occupational exposure to cytostatics and health risks constitutes employers' obligation. Unfortunately, the assessment of occupational risk resulting from exposure to cytostatics raises a number of concerns. Provisions governing the problem of workers' health protection are not unequivocal because they derive from a variety of law areas, especially in a matter of hazard classification and safety data sheets for cytostatics. Moreover, no legally binding occupational exposure limits have been set for cytostatics or their active compounds, and analytical methods for these substances airborne and biological concentrations are lacking. Consequently, the correct assessment of occupational exposure to cytostatics, the evaluation of health hazards and the development of the proper preventive strategy appear difficult. The authors of this article described and discussed the amendments to the European provisions concerning chemicals in the light of employers' obligations in the field of employees' heath protection against the consequences of exposure to cytostatics. Some modifications aimed at a more effective health protection of workers occupationally exposed to cytostatics were also proposed. Int J Occup Med Environ Health. 2019;32(2):141-59.
CitationInt J Occup Med Environ Health 2019;32(2):121–140
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States
- [Hygiene and legal aspects of occupational exposure assessment to cytostatics].
- Authors: Kupczewska-Dobecka M, Pałaszewska-Tkacz A, Czerczak S, Konieczko K
- Issue date: 2018 Jan 1
- [Fluorouracil and doxorubicin - cardiotoxic cytostatics in the workplace].
- Authors: Kupczewska-Dobecka M, Czerczak S
- Issue date: 2020 May 15
- [Regulations for the protection of workers against the effects of hazardous substances at the workplace].
- Authors: Wolf T
- Issue date: 2008 Mar
- [Carcinogenic or mutagenic chemical substances and technological processes in the workplace in Poland in 2013-2017].
- Authors: Niepsuj A, Czerczak S, Konieczko K
- Issue date: 2020 Mar 30
- [Knowledge of the employees about biological agents in the work environment and the ways of health protection against occupational exposure to biological hazards. Part II].
- Authors: Kozajda A, Zielińska-Jankiewicz K, Szadkowska-Stańczyk I
- Issue date: 2005